A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208) - Concepedia

Concepedia

Publication | Closed Access

A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208)

58

Citations

34

References

2018

Year

Shogo Kobayashi, Hiroaki Nagano, Akira Tomokuni, Kunihito Gotoh, Daisuke Sakai, Etsuro Hatano, Satoru Seo, Hiroaki Terajima, Yoichiro Uchida, Tetsuo Ajiki,

Annals of Surgery

Abstract

The comparison of the survival of the 2 groups revealed that adjuvant S-1 therapy may be superior to adjuvant GEM therapy after major hepatectomy for BTC.

References

	Year	Citations

Page 1